Erasca, Inc.
NASDAQ:ERASBiotechnology
-$0.02 today
- Market cap
- $4.83B
- Beta
- 0.73
- P/E (TTM)
- -15.3
- EPS (TTM)
- -$0.91
Volume 8.94M
Average 6.79M
ERAS Operating Income
Profit from core operations after operating expenses, before interest and taxes.
Erasca, Inc.NASDAQ: ERAS
Operating Income · Q3 FY2026 · quarter ended Sep 2026
Operating income remains negative
Q3 FY2026 operating income was -$59.52M, compared with -$34.55M a year earlier. Trailing-twelve-month operating income was -$177.66M.
Context
- Operating income grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether operating income reaches the consensus estimate from 5 analysts of $0 (+100.0%) for the fiscal year ending Dec 2026, a step up from the +26.8% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- -$59.52M-25.0% QoQ
- Last fiscal yearDec 2025
- -$131.41M+26.8% YoY
- LTMSep 2026
- -$177.66M-23.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -72.3% | +100.0% | +172.3 pp |
| 1 year | +26.8% | +100.0% | +73.2 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Income history
USD · from the income statement
- Latest · FY2025
- (131.41M) USD
- Year-over-year change
- +26.8%
| Period | Period end | Operating Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (131.41M) | +26.8% |
| FY2024 | 2024-12-31 | (179.59M) | -26.9% |
| FY2023 | 2023-12-31 | (141.53M) | +42.8% |
| FY2022 | 2022-12-31 | (247.45M) | -98.1% |
| FY2021 | 2021-12-31 | (124.88M) | — |
Operating Income vs competitors
How ERAS compares with its peers on the latest reported figures
- ERAS's LTM Sep 2026 operating income of -$177.66M is the 5th highest of the 9 companies compared; the peer median is -$177.16M.
- Its year-over-year change of -23.4% is the 5th highest of 9, against a peer median of -21.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | -$137.63M | +38.7% | — | 81.0% | |
| LTM Mar 2026 | -$149.91M | -2.2% | — | — | |
| LTM Mar 2026 | -$156.87M | -11.7% | — | — | |
| LTM Mar 2026 | -$170.85M | -30.3% | — | 344.6% | |
| LTM Sep 2026 | -$177.66M | -23.4% | — | — | |
| LTM Mar 2026 | -$183.47M | +49.1% | — | 81.4% | |
| LTM Sep 2026 | -$228.53M | -107.1% | — | — | |
| LTM Mar 2026 | -$317.75M | -56.2% | — | 443.5% | |
| LTM Jun 2026 | -$1.63B | -81.3% | — | — | |
| Peer median (excluding ERAS) | -$177.16M | -21.0% | — | 213.0% | |
Competitors are the stored peer set for ERAS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 829K | 2.64M | 3.73M | 0 | 3.11M |
| Gross Profit | (829K) | (2.64M) | (3.73M) | 0 | (3.11M) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 73.92M | 112.46M | 103.82M | 115.36M | 92.85M |
| Selling, General & Admin | 22.62M | 32.99M | 37.7M | 41.73M | 38.55M |
| Operating Expenses | 124.05M | 244.81M | 137.79M | 179.59M | 128.3M |
| Depreciation & Amortization | 829K | 2.64M | 3.73M | 3.81M | 3.11M |
| EBITDA | (121.94M) | (240.16M) | (121.31M) | (153.28M) | (121.44M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (124.88M) | (247.45M) | (141.53M) | (179.59M) | (131.41M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 190K | 4.9M | 16.71M | 20.09M | 16.61M |
| Interest Expense | 0 | 201.36M | 0 | 0 | 0 |
| Other Income / Expenses | 2.12M | 4.65M | 16.48M | 17.94M | 6.86M |
| Income Before Tax | (122.76M) | (242.81M) | (125.04M) | (161.65M) | (124.55M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (122.76M) | (242.81M) | (125.04M) | (161.65M) | (124.55M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (1.03) | (1.99) | (0.83) | (0.69) | (0.44) |
| EPS (Diluted) | (1.03) | (1.99) | (0.83) | (0.69) | (0.44) |
| Weighted Avg Shares | 119.1M | 122.02M | 150.18M | 233.82M | 283.53M |
| Weighted Avg Shares (Diluted) | 119.1M | 122.02M | 150.18M | 233.82M | 283.53M |
Erasca, Inc.
NASDAQ:ERAS
Intrinsic Alpha fair value
Locked
Current Price
$13.76
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.